Indian drug firms use S.Africa to access continenteastern cape

Thanks to cheap Indian drugs, it has been able to increase the proportion of AIDS patients on treatment from two percent in 2003 to 37 percent in 2009.

The relationship was cemented in 2001 when Cipla announced it would supply anti-AIDS drugs to Africa at a massive discount, slashing the per-patient price of the AIDS cocktail from more than $10,000 a year to less than $400.

But the Indian firms have gained more than just goodwill in the bargain. Providing discount generics has been big business and helped the Indian industry displace its Western rivals.

That close and burgeoning political relationship has translated into quite a strong commercial relationship.

Verachia said the thriving pharmaceutical partnerships are part of a larger vision of south-south cooperation that South Africa and India share.

Sub-Saharan Africa, which has an estimated 22.5 million HIV positive people — 68 percent of all infections globally — is chronically short of funds to fight the disease.

otages pmargin:0;padding:0.detenufont:bold 14px Arial, Helvetica, sans-serif;color:FFFFFF;padding-top:139px !important;text-transform:uppercase;text-align:center.detenu acolor:FFFFFF.compteurtext-align:center;font:bold 18px Arial, Helvetica, sans-serif;color:FFFFFF

Unlike most multinational companies, Indias big three pharmaceuticals — Ranbaxy, Cipla and Dr Reddys — have carefully cultivated their local credentials by bringing South Africans into the top corporate echelons.

Theyve been very sIndian drug firms use S.Africa to access continenteastern capetrategic in terms of how theyve positioned themselves in South Africa and using South Africa as a launch pad into Africa, said Abdullah Verachia, an analyst at consulting firm Frontier Advisory who has followed the Indian companies ascent.

Indian pharmaceutical companies have been absolutely critical in bringing down the cost of treatment, Francois Venter, head of the South African HIV Clinicians Society, told AFP.

block-block-261padding:0;border:0 !importantblock-block-261 .contentpadding:0;border:0 !important

Indias pharmaceutical industry has transformed itself over the past three decades from almost non-existent to the second-largest in the world by volume, with revenues of $3 billion (two billion euros).

Soueastern cape department health tendersth Africa, which has 5.6 million people living with HIV, in 2008 launched a tender worth $526 million to provide its health departments anti-AIDS drugs for two years, giving preference to companies with local operations.

Cipla, the countrys sixth-largest pharmaceutical, has announced a $36-million upgrade to its plant in the eastern city of Durban.

.popitcontentmargin:0; padding:0;position: absolute;top: 0%;left: 0%;width: 5000height: 5000 background-color: 000;z-index:3;opacity:0.8;filter: alpha(opacity=80).zoneurl z-index:400000000000; popit div a text-decoration: none; font:normal 15px Lucida Grande,arial; color:212121closer a text-decoration: none; font:normal 15px Lucida Grande,arial; color:212121popit display:none

.footer-v2-floatleftfloat:left.footer-v2-col1,.footer-v2-col2,.footer-v2-col3,.footer-v2-col4 width:170overflow:hidden;text-align:left/.footer-v2-col1 width:195overflow:hidden;text-align:left/.footer-v2-vseparatorwidth:1background-color:365E9A;height:180margin:0 10px 0 10overflow:hidden.footer-v2-conteneur ul li,.footer-v2-conteneur ul li alist-style:none;text-decoration:none;margin:0;padding:0;color:FFFFFF.footer-v2-conteneur ul li a:hovertext-decoration:underline.footer-v2-col2 ul,.footer-v2-col3 ul,.footer-v2-col4 ul,.footer-v2-subcol1 ul,.footer-v2-subcol2 ulmargin:0 !important;padding:0;text-align:left.footer-v2-conteneur font:normal 12px Arial, Helvetica, sans-serif;color:FFF;background-color:183C6D;padding:22px 12px 22px 12height:220.footer-v2-conteneur h1font:bold 14px Arial, Helvetica, sans-serif;color:FFF;text-transform:uppercase;margin:0 0 20px 0;padding:0.footer-v2-subcol1width:80.footer-v2-copyrightfont:normal 10px Arial, Helvetica, sans-serif;color:999999;margin:10px 0

A blood test is carried out at a roadside AIDS testing table in the South African city of Cape Town. Thanks to cheap Indian drugs, Sub-Saharan Africa has been able to increase the proportion of AIDS patients on treatment from two percent in 2003 to 37 percent in 2009.

If the cost of treatment hadnt come down, there would be very many fewer people on the drugs.

.rdp-link afont:bold 13px Arial !important;line-height:15text-decoration:none;display:block;text-align:left;width:220overflow:hidden;margin-bottom:5.rdp-link p margin: 5px 0; font-size: 11.rdp-bloc/margin-top:4/margin-left:15.rdp-bloc-stylepadding:10background:url( no-repeat;width:280 height:245padding:10px 0.rdp-bloc imgpadding:2padding-left: 0;margin-left: 0;margin-right:4

Laboratory researchers are seen at the Ranbaxy Laboratories in Mumbai. India&039;s pharmaceutical industry has rolled out a strong local presence in South Africa, cornering a large share of the market and using the country as a base to gush a flood of cheap generic drugs into Africa.

That reflects one, their understanding of the market and two, their commitment to South Africa. You seldom get a foreign multinational company appointing a local CEO, he told AFP.

We share a very close diplomatic and political relationship in that both countries are advancing the interests of the south, he said.

AFP – A white South African woman runs the local operations of Indias largest drug company, Ranbaxy, and the second largest, Cipla, is listed on the Johannesburg Stock Exchange.

.service-floatleftfloat:left.service-conteneur width:280height:110display:block;padding-top:5padding-left:5.service-titrebackground-color:F5F5F7;width:288height:20padding-left:5.service-colonnewidth:130.service-titre,.service-titre afont:bold 10px Arial, Helvetica, sans-serif;text-decoration:none;text-transform:uppercase;line-height:20color:003366;margin-bottom:11.service-nom,.service-nom afont:bold 10px Arial, Helvetica, sans-serif;text-decoration:none;line-height:15color:003366;padding-left:5.service-lineheight:30overflow:hidden;clear:both.service-logowidth:30px !important;float:left

South African firm Aspen Pharmacare took the lions share of the contract, but Ranbaxys local joint venture Sonke won 4.5 percent of the deal and Cipla Medpro, Ciplas local subsidiary, won 1.9 percent.

Indias pharmaceutical industry has rolled out a strong local presence in South Africa, cornering a large share of the market and using the country as a base to gush a flood of cheap generic drugs into Africa.

Ranbaxy and Cipla have also won ns by slashing the price of anti-AIDS drugs, saving countless lives in the country with the worlds largest HIV epidemic.

Indian drug firms use S.Africa to access continenteastern cape,Chief Executive Officer and Managing Director of Indian pharmaceutical company Ranbaxy Malvinder Singh. Ranbaxy, today South Africa&039;s fifth-largest pharmaceutical company, last year opened a $30-million manucturing cility west of Johannesburg – its second.

Ranbaxy, today South Africas fifth-largest pharmaceutical company, last year opened a $30-million manucturing cility west of Johannesburg — its second.

Cheap generic drugs have been the catalysts of that growth, and Africa has been a key market, buying 14 percent of Indias $8-billion pharmaceutical exports in 2009.

Leave a Reply